Used as a key intermediate in the synthesis of kinase inhibitors, particularly in pharmaceutical research targeting cancer therapies. It plays a role in the development of selective inhibitors for protein kinases involved in cell signaling pathways, offering potential in treating conditions like chronic myeloid leukemia and other malignancies. Its structure allows for modification to enhance binding affinity and selectivity toward specific enzyme targets. Also employed in research settings to study signal transduction mechanisms and to design new bioactive molecules with improved pharmacokinetic profiles.